SAGA Diagnostics AB
SAGA Diagnostics redefines early cancer detection using ultra-sensitive MRD testing.
Oversigt
- 20–49
- Medarbejdere
- 300–399t SEK
- Omsætning
- 2016
- Grundlagt
Nøglebeslutningstagere
Roger Gunnarsson
Non-Executive Director
Brian Krueger
VP Technology Development
Ramez Sousou
Non-Executive Director
Brian Dow
Chief Financial Officer
+10 flere kontakter i Funnelfeedr
Beskrivelse
SAGA Diagnostics is a biotechnology company focused on intercepting cancer at its earliest, most treatable stages. Their core mission revolves around redefining the early detection of Molecular Residual Disease (MRD) to provide greater insight for treatment decisions. The company's flagship product,...